# EDGAR Filing Document

**Accession Number:** 0000277135
**File Stem:** 0001209191-23-019384
**Filing Date:** 2023-3
**Character Count:** 12329
**Document Hash:** 21195e3029fbf73e52b3a0593a7141f6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001209191-23-019384.hdr.sgml**: 20230316

**ACCESSION NUMBER**: 0001209191-23-019384

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230315

**FILED AS OF DATE**: 20230316

**DATE AS OF CHANGE**: 20230316

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Merriwether Deidra C
- **CENTRAL INDEX KEY:** 0001757570

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-05684
- **FILM NUMBER:** 23739928

**MAIL ADDRESS:**
- **STREET 1:** 100 GRAINGER PARKWAY
- **CITY:** LAKE FOREST
- **STATE:** IL
- **ZIP:** 60045
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** W.W. GRAINGER, INC.
- **CENTRAL INDEX KEY:** 0000277135
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DURABLE GOODS [5000]
- **IRS NUMBER:** 361150280
- **STATE OF INCORPORATION:** IL
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 100 GRAINGER PARKWAY
- **CITY:** LAKE FOREST
- **STATE:** IL
- **ZIP:** 60045-5201
- **BUSINESS PHONE:** 847-535-1000

**MAIL ADDRESS:**
- **STREET 1:** 100 GRAINGER PARKWAY
- **CITY:** LAKE FOREST
- **STATE:** IL
- **ZIP:** 60045

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GRAINGER W W INC
- **DATE OF NAME CHANGE:** 19920703

## Ex-24

```
<PRE>
POWER OF ATTORNEY

Know all by these presents that, the undersigned hereby
constitutes and appoints each of John L. Howard, Nicholas
Eichenseer, and J. Colin McGee, signing singly, the
undersigned's true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned Forms 3, 4, 5 and 144
relating to equity securities of W.W. Grainger, Inc. (the "Company")
in accordance with Section 16(a) of the Securities Exchange Act of 1934,
and the rules and regulations thereunder and Rule 144 under the
Securities Act of 1933;

(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete any such Form 3, 4, 5, or 144
and timely file the same with the United States Securities and Exchange
Commission and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of the attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned,
it being understood that the documents executed by the attorney-in-fact
on behalf of the undersigned pursuant to this Power of Attorney shall be
in such form and shall contain such terms and conditions as the
attorney-in-fact may approve in his or her discretion.

The undersigned hereby grants to each attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever
requisite, necessary or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes
as the attorney-in-fact might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all that
the attorney-in-fact, or his or her substitute or substitutes, shall lawfully
do or cause to be done by virtue of this Power of Attorney and the rights and
powers herein granted.

The undersigned acknowledges that the attorneys-in-fact, in serving
in such capacity at the request of the undersigned, is assuming, nor is
the Company assuming, any of the undersigned's responsibilities to comply to
comply with Section 16 of the Exchange Act of 1934 or Rule 144 under the
Securities Act of 1933.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, 5, and 144 with
respect to the undersigned's holdings of and transactions in equity
securities of the Company, unless earlier revoked by the undersigned
in a signed writing delivered to the attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of the 21st day of July, 2022 and revokes any previously
adopted power of attorney with respect to the rights and powers herein
granted.

/s/Deidra C. Merriwether
Deidra C. Merriwether
</PRE>
```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Merriwether Deidra C<br><sub>(Last) (First) (Middle)</sub><br>100 GRAINGER PARKWAY<br><sub>(Street)</sub><br>LAKE FOREST, IL 60045<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Sr. VP & CFO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>W.W. GRAINGER, INC. [ GWW ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-03-15 |  | M |  | 2127 | A | $248.22 | 9732 | D |  |
| Common Stock | 2023-03-15 |  | M |  | 2496 | A | $231.88 | 12228 | D |  |
| Common Stock | 2023-03-15 |  | S |  | 490 | D | 656.7837<sup>(1)</sup> | 11738 | D |  |
| Common Stock | 2023-03-15 |  | S |  | 500 | D | 659.3571<sup>(2)</sup> | 11238 | D |  |
| Common Stock | 2023-03-15 |  | S |  | 400 | D | 660.544<sup>(3)</sup> | 10838 | D |  |
| Common Stock | 2023-03-15 |  | S |  | 400 | D | 661.6248<sup>(4)</sup> | 10438 | D |  |
| Common Stock | 2023-03-15 |  | S |  | 300 | D | 664.4733<sup>(5)</sup> | 10138 | D |  |
| Common Stock | 2023-03-15 |  | S |  | 463 | D | 665.4981<sup>(6)</sup> | 9675 | D |  |
| Common Stock | 2023-03-15 |  | S |  | 565 | D | 666.4974<sup>(7)</sup> | 9110 | D |  |
| Common Stock | 2023-03-15 |  | S |  | 605 | D | 669.0122<sup>(8)</sup> | 8505 | D |  |
| Common Stock | 2023-03-15 |  | S |  | 400 | D | 669.7292<sup>(9)</sup> | 8105 | D |  |
| Common Stock | 2023-03-15 |  | S |  | 400 | D | 670.865<sup>(10)</sup> | 7705 | D |  |
| Common Stock | 2023-03-15 |  | S |  | 100 | D | $673.23 | 7605 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option | $248.22 | 2023-03-15 |  | M |  |  | 2127 | 2017-04-30 | 2024-04-29 | Common Stock | 2127 | $0.00 | 0 | D |  |
| Stock Option | $231.88 | 2023-03-15 |  | M |  |  | 2496 | 2018-04-01 | 2025-03-31 | Common Stock | 2496 | $0.00 | 0 | D |  |
| Stock Option | $234.38 |  |  |  |  |  |  | 2019-04-01 | 2026-03-31 | Common Stock | 2860 |  | 2860 | D |  |
| Stock Option | $231.20 |  |  |  |  |  |  | 2020-04-03 | 2027-04-02 | Common Stock | 2318 |  | 2318 | D |  |
| Stock Option | $276.64 |  |  |  |  |  |  | 2021-04-02 | 2028-04-01 | Common Stock | 3123 |  | 3123 | D |  |
| Stock Option | $311.26 |  |  |  |  |  |  | <sup>(11)</sup> | 2029-03-31 | Common Stock | 2339 |  | 2339 | D |  |

---

### Footnotes:

(1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $656.6564 to $656.96, inclusive. The reporting person undertakes to provide W.W. Grainger, Inc., any security holder of W.W. Grainger, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (10).

(2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $658.89 to $659.84, inclusive.

(3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $660.07 to $661.05, inclusive.

(4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $661.4183 to $662.13, inclusive.

(5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $664.02 to $664.70, inclusive.

(6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $665.08 to $666.06, inclusive.

(7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $666.1980 to $666.77, inclusive.

(8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $668.52 to $669.42, inclusive.

(9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $669.62 to $669.9669, inclusive.

(10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $670.63 to $671.18, inclusive.

(11) The stock option fully vested in three years, where 1/3 vested on April 1, 2020, 1/3 vested on April 1, 2021, and the remainder vested on April 1, 2022.

**Remarks:**
Exhibit List - Exhibit 24 - Power of Attorney

**Signature:** J. Colin McGee, by POA from Deidra C. Merriwether, SVP and CFO  
**Date:** 2023-03-16

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**